Author/Creator: Bornstein, S.R. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Bornstein, S.R.

1. Asymmetric dimethylarginine (ADMA) mediates the effect of miRNA-762 on all-cause mortality in patients with coronary artery disease (CAD). (August 2021)

Authors:: Tselmin, S.; Kleber, M.; Jarzebska, N.; März, W.; Jin, H.; Bornstein, S.R.; Mangoni, A.; Rodionov, R.N.
Journal:: Atherosclerosis
Issue:: Volume 331(2021)
Page Start:: e222
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Dysregulation of the CD4+ T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study. (November 2017)

Authors:: Papin, J.; Brennand, A.; Arbore, G.; Hohenstein, B.; Kamvissi, V.; Kemper, C.; Bornstein, S.R.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 238
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Elevated lipoprotein(a) levels result in a high cardiovascular risk – A prospective analysis of a lipidology outpatients unit. (September 2016)

Authors:: Schatz, U.; Fischer, S.; Julius, U.; Bornstein, S.R.; Tselmin, S.
Journal:: Atherosclerosis
Issue:: Volume 252(2016)
Page Start:: e127
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemia. (November 2017)

Authors:: Tselmin, S.; Müller, G.; Schatz, U.; Julius, U.; Bornstein, S.R.; Hohenstein, B.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 209
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Lipoprotein apheresis influences monocyte subpopulations. (November 2017)

Authors:: Jellinghaus, S.; Reich, C.; Schatz, U.; Tselmin, S.; Ibrahim, K.; Pfluecke, C.; Schauer, A.; Bornstein, S.R.; Hohenstein, B.; Strasser, R.H.; Julius, U.; Poitz, D.M.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 108
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study. (November 2017)

Authors:: Schatz, U.; Tselmin, S.; Müller, G.; Julius, U.; Hohenstein, B.; Fischer, S.; Bornstein, S.R.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 246
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. (May 2015)

Authors:: Schatz, U.; Illigens, B.M.W.; Siepmann, T.; Arneth, B.; Siegert, G.; Siegels, D.; Heigl, F.; Hettich, R.; Ramlow, W.; Prophet, H.; Bornstein, S.R.; Julius, U.
Journal:: Atherosclerosis
Issue:: Volume 18(2015)
Page Start:: 199
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Transgenic overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II - induced cardiac hypertrophy and vascular remodeling. (August 2021)

Authors:: Kopaliani, I.; Jarzebska, N.; Brilloff, S.; Kolouschek, A.; Martens-Lobenhoffer, J.; Bornstein, S.R.; Bode-Böger, S.M.; Weiss, N.; Deussen, A.; Rodionov, R.N.
Journal:: Atherosclerosis
Issue:: Volume 331(2021)
Page Start:: e96
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗